CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH). In research settings, CJC-1295 with DAC has been studied for its ability to bind to GHRH receptors and influence endogenous growth hormone release over an extended duration due to the presence of the DAC component.

CJC-1295 with DAC is commonly researched in laboratory and in-vitro models examining growth hormone signaling pathways, endocrine regulation, and metabolic processes. Its prolonged activity profile makes it of interest in studies focused on sustained hormone signaling, physiological regulation, and peptide stability.

Disclaimer

For laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic purposes.